Clinical Trial: Arginine Replacement Therapy in COVID-19
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: Prospective Open-Label Pilot Study of Arginine Replacement Therapy in Children Hospitalized With COVID-19
Brief Summary:
The purpose of this study is to investigate if receiving doses of arginine (a protein in the body) will improve mitochondria function in children with COVID-19.The study will be performed in Children's Healthcare of Atlanta, Egleston campus.Patients will be randomized to receive one of three doses of arginine three times a day for five days or at discharge whichever comes first.
Read more